Bally, Alexander PR, James W, Austin, Jeremy MB (2016) Genetic and epigenetic regulation of PD-1 expression. J Immunol 196:2431–2437

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bloem BR, Okun MS, Klein C (2021) Lancet, vol 397. ‘Parkinson’s disease’, pp 2284–2303

Chang Y-H, Wu K-C, Harn H-J, Lin S-Z, Dah-Ching D (2018) Exosomes and stem cells in degenerative disease diagnosis and therapy. Cell Transplant 27:349–363

Article  PubMed  PubMed Central  Google Scholar 

Choong C-J, and Hideki Mochizuki (2023) Involvement of mitochondria in parkinson’s disease. Int J Mol Sci 24:17027

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daśko M, de Pascual-Teresa B, Ortín I and A. Ramos (2022) ‘HDAC Inhibitors: Innovative Strategies for Their Design and Applications’. Molecules, 27

de Ruijter AJM, Albert H, van Huib GENNIP N, Caron Stephan Kemp, and André BP van KUILENBURG (2003) ‘Histone deacetylases (HDACs): characterization of the classical HDAC family’. Biochem J 370:737–749

Article  PubMed  PubMed Central  Google Scholar 

Duan R, Shi L, Deng Y, Wu J, Wang S, Peng Q, Li Z, Xu Z, Wang F, Xue X, Gao Q (2024) AVE0991 ameliorates dopaminergic neuronal damage in parkinson’s disease through HOTAIRM1/miR-223-3p/α-synuclein axis. Sci Rep 14:26346

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaub P, Tedeschi A, Puttagunta R, Nguyen T, Schmandke A, Di Giovanni S (2010) HDAC Inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation. Cell Death Differ 17:1392–1408

Article  CAS  PubMed  Google Scholar 

González PA, Iglesias, Melisa A, Conde Verónica, González-Pardo RM, Uranga, Gabriela AS (2019) In vitro 6-hydroxydopamine-induced neurotoxicity: new insights on NFκB modulation. Toxicol in Vitro 60:400–411

Article  Google Scholar 

Guan L, Hao Q, Shi F, Gao B, Wang M, Zhou X, Han T, Wenjie Ren (2023) Regulation of the tumor immune microenvironment by cancer-derived circular RNAs. Cell Death Dis 14:132

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo M, Ji X, Liu J (2022) Hypoxia and alpha-Synuclein: inextricable link underlying the pathologic progression of parkinson’s disease. Front Aging Neurosci 14:919343

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hlushchuk I, Ruskoaho H, Domanskyi A, Airavaara M, Mika JV (2021) Domain-independent Inhibition of CBP/p300 attenuates α-synuclein aggregation. ACS Chem Neurosci 12:2273–2279

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang M, Lou D, Charli A, Kong D, Jin H, Zenitsky G, Anantharam V, Kanthasamy A, Wang Z, Anumantha GK (2021) Mitochondrial dysfunction–induced H3K27 hyperacetylation perturbs enhancers in parkinson’s disease. JCI Insight 6:e138088

Article  PubMed  PubMed Central  Google Scholar 

Huang M, Malovic E, Ealy A, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG (2023) Microglial immune regulation by epigenetic reprogramming through histone H3K27 acetylation in neuroinflammation. Front Immunol 14:1052925

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jodo A, Shibazaki A, Onuma A, Kaisho T, Tanaka T (2020) PDLIM7 synergizes with PDLIM2 and p62/Sqstm1 to inhibit inflammatory signaling by promoting degradation of the p65 subunit of NF-κB. Front Immunol 11:1559

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klokkaris A, Migdalska-Richards A (2024) An overview of epigenetic changes in the parkinson’s disease brain. Int J Mol Sci 25:6168

Article  CAS  PubMed  PubMed Central  Google Scholar 

Labbé C, Lorenzo-Betancor O, Owen AR (2016) Epigenetic regulation in parkinson’s disease. Acta Neuropathol 132:515–530

Article  PubMed  PubMed Central  Google Scholar 

Lampugnani M, Grazia L, Bravi, and Elisabetta Dejana (2015). ‘The role of microvascular endothelial WNT signaling the formation of the blood brain barrier’, SpringerPlus, 4: L47

Landgrave-Gómez, Jorge Octavio Mercado-Gómez, and Rosalinda Guevara-Guzmán (2015) ‘Epigenetic mechanisms in neurological and neurodegenerative diseases’. Front Cell Neurosci 9:58

PubMed  PubMed Central  Google Scholar 

Lang AE, Alberto JE (2018) Disease modification in parkinson’s disease: current approaches, challenges, and future considerations. Mov Disord 33:660–677

Article  PubMed  Google Scholar 

Lesage S, Trinh J (2023) ‘Special Issue Parkinson’s Disease: Genetics and Pathogenesis’, Genes (Basel), 14

Li G, Ma J, Cui S, He Y, Xiao Q, Liu J, Chen S (2019) Parkinson’s disease in china: a forty-year growing track of bedside work. Transl Neurodegener 8:22

Article  PubMed  PubMed Central  Google Scholar 

Olawade DB, Intishar Rashad E, Egbon J, Teke SV, Ovsepian, Stergios Boussios (2025) Reversing epigenetic dysregulation in neurodegenerative diseases: mechanistic and therapeutic considerations. Int J Mol Sci 26:4929

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pajares M, Rojo AI (2020) Gina Manda, Lisardo Boscá, and Antonio Cuadrado. ‘Inflammation in Parkinson’s disease: mechanisms and therapeutic implications’, Cells, 9:1687

Rasheed M, Liang J, Wang C, Deng Y, Chen Z (2021) Epigenetic regulation of neuroinflammation in parkinson’s disease. Int J Mol Sci 22:4956

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raucci A, Zwergel C, Valente S, Mai A (2025) Advancements in Hydrazide-Based HDAC inhibitors: A review of recent developments and therapeutic potential. J Med Chem 68:14171–14194

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosete C, Annie Vogel C (2024) The two faces of HDAC3: neuroinflammation in disease and neuroprotection in recovery. Epigenomics 16:1373–1388

Article  CAS  PubMed  PubMed Central  Google Scholar 

Słowikowski B, Owecki W, Jeske JMichał, Jezierski Michał, Draguła Ulyana Goutor, Paweł P Jagodziński, Wojciech Kozubski, Jolanta Dorszewska (2024) ‘Epigenetics and the neurodegenerative process’. Epigenomics 16:473–491

Article  PubMed  Google Scholar 

Surguchov A (2023) α-Synuclein and mechanisms of epigenetic regulation. Brain Sci 13:150

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of parkinson’s disease. Lancet Neurol 20:385–397

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsui D, Voronova A, Gallagher D, Kaplan DR, Miller FD, Wang J (2014) CBP regulates the differentiation of interneurons from ventral forebrain neural precursors during murine development. Dev Biol 385:230–241

Article  CAS  PubMed  Google Scholar 

Wang J, Dai L, Chen S, Zhang Z, Fang X, Zhang Z (2024) Protein-protein interactions regulating α-synuclein pathology. Trends Neurosci 47:209–226

Article  CAS  PubMed  Google Scholar 

Yang F, Yang M, Liu Y, Zhou C, Chen Y, Wu J, Zhang X, Shengjun Xiao (2024) PDLIM7 promotes tumor metastasis in papillary thyroid carcinoma via stabilizing focal adhesion kinase protein. Thyroid 34:598–610

Article  CAS  PubMed  Google Scholar 

Zhou M, Xu K, Ge J, Luo X, Wu M, Wang N, and Jianfeng Zeng (2024) Targeting ferroptosis in parkinson’s disease: mechanisms and emerging therapeutic strategies. Int J Mol Sci 25:13042

Article  CAS  PubMed  PubMe